Similar articles

• [Thalassemia major: chelating therapy with deferoxamine].

  Abreu de Miani MS, Sanchis de Herrlein MS, Peñalver JA. Abreu de Miani MS, et al. Medicina (B Aires). 1985;45(3):231-4. Medicina (B Aires). 1985. PMID: 3841934 Spanish. No abstract available.
• Iron chelation therapy with deferoxamine in Cooley anemia.

  Cohen A, Schwartz E. Cohen A, et al. J Pediatr. 1978 Apr;92(4):643-7. doi: 10.1016/s0022-3476(78)80314-x. J Pediatr. 1978. PMID: 633031
• Intensive iron-chelation in thalassaemia.

  [No authors listed] [No authors listed] Br Med J. 1978 Sep 16;2(6140):782-3. doi: 10.1136/bmj.2.6140.782. Br Med J. 1978. PMID: 698731 Free PMC article. No abstract available.
• Desferrioxamine: its use in iron chelation in thalassemia.

  Sharma BK, Choudhury P, Dubey AP. Sharma BK, et al. Indian Pediatr. 1990 Mar;27(3):314-9. Indian Pediatr. 1990. PMID: 2190932 Review. No abstract available.
• Consequences and costs of noncompliance with iron chelation therapy in patients with transfusion-dependent thalassemia: a literature review.

  Delea TE, Edelsberg J, Sofrygin O, Thomas SK, Baladi JF, Phatak PD, Coates TD. Delea TE, et al. Transfusion. 2007 Oct;47(10):1919-29. doi: 10.1111/j.1537-2995.2007.01416.x. Transfusion. 2007. PMID: 17880620 Review.